ArticleLight, science & applications2025
Exceptionally high brightness and long lifetime of efficient blue OLEDs for programmable active-matrix display.
Article in Light, science & applications, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed.
- Origin of Enhanced Efficiency and Reduced Roll-Off in Organic Light-Emitting Diodes Based on Pt(II) Complexes.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026Article
- Molecular conformation engineering in central 8π-electron system toward unique aggregation-induced ultra-narrowband emission with a FWHM of 13 nm.Light, science & applications · 2026Article
- Red OLED with efficiency of 25.6% at 10,000 cd mLight, science & applications · 2026Review
- Hybrid Tandem White Light-Emitting Diodes Based on GaN and Organic Emitters.Materials (Basel, Switzerland) · 2025Article
- Dual Regulation of Molecular Rigidity and Orbital Engineering of Pt(II) Emitters for High-Performance Deep-Blue OLEDs.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025Article
- Polymerization-Induced Direct Photolithography of Quantum Dots.Macromolecular rapid communications · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
20 authors.
Funding
Abstract
Blue phosphorescent OLEDs (Ph-OLEDs) have long faced critical challenges in efficiency, stability and brightness, which are crucial for advanced display. Herein, we introduce two novel Ir(III) emitters featuring a 3,6-di(tert-butyl)-9H-carbazolyl (tBuCz) substituted tridentate carbene pincer ligand, significantly improving efficiency and stability. The tBuCz-m-CF3 and tBuCz-p-CF3 complexes are designed to enhance steric encumbrance and minimize exciton accumulation. These innovations lead to exceptional photoluminescence quantum yields (PLQY) of 98% and an impressive decay rate constant of 7.97 × 10
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.